ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 212 filers reported holding ALKERMES PLC in Q4 2020. The put-call ratio across all filers is 5.64 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,703,000 | +134.9% | 76,245 | +213.2% | 0.10% | +197.1% |
| Q2 2022 | $725,000 | +13.3% | 24,344 | +0.1% | 0.04% | -2.8% |
| Q1 2022 | $640,000 | -74.6% | 24,310 | -77.6% | 0.04% | -61.7% |
| Q4 2021 | $2,523,000 | +74.8% | 108,475 | +131.8% | 0.09% | +25.3% |
| Q3 2021 | $1,443,000 | +236.4% | 46,787 | +167.4% | 0.08% | +316.7% |
| Q2 2021 | $429,000 | -79.3% | 17,498 | -84.3% | 0.02% | -84.5% |
| Q1 2021 | $2,075,000 | +316.7% | 111,106 | +344.7% | 0.12% | +182.9% |
| Q4 2020 | $498,000 | +6.6% | 24,984 | -11.3% | 0.04% | -19.6% |
| Q3 2020 | $467,000 | +65.0% | 28,177 | +43.3% | 0.05% | +50.0% |
| Q1 2020 | $283,000 | -33.4% | 19,660 | -5.7% | 0.03% | -2.9% |
| Q4 2019 | $425,000 | -72.8% | 20,844 | -74.0% | 0.04% | -63.2% |
| Q3 2019 | $1,561,000 | -22.7% | 80,035 | -10.7% | 0.10% | -45.7% |
| Q2 2019 | $2,019,000 | +130.5% | 89,584 | +201.9% | 0.18% | -32.7% |
| Q4 2018 | $876,000 | – | 29,675 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 7,950,000 | $148,506,000 | 14.24% |
| Krensavage Asset Management, LLC | 1,627,323 | $30,398,000 | 10.52% |
| Healthcare Value Capital, LLC | 100,000 | $1,868,000 | 4.16% |
| Camber Capital Management LP | 5,600,000 | $104,608,000 | 3.59% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $65,828,000 | 1.51% |
| CM Management, LLC | 70,000 | $1,308,000 | 0.97% |
| PRICE MICHAEL F | 305,000 | $5,697,000 | 0.68% |
| Palo Alto Investors LP | 487,100 | $9,099,000 | 0.52% |
| SEIZERT CAPITAL PARTNERS, LLC | 463,600 | $8,660,000 | 0.45% |
| Birchview Capital, LP | 35,000 | $654,000 | 0.39% |